A study for a 40 year old woman who takes Zofran, Abilify - from FDA reports

65 females aged 40 (±5) who take the same drugs are studied. This is a personalized study for a 40 year old female patient who has Nausea And Vomiting, Depression. The study is created by eHealthMe based on reports from FDA.

On Apr, 16, 2018

65 females aged 40 (±5) who take Zofran, Abilify are studied.

Number of reports submitted per year:

Zofran, Abilify for a 40-year old woman.

Information of the patient in this study:

  • Age: 40
  • Gender: female
  • Conditions: Nausea And Vomiting, Depression
  • Drugs taken:
    • Zofran (ondansetron hydrochloride)
    • Abilify (aripiprazole)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • Memory loss
  • Mania (a state of abnormally elevated or irritable mood)
  • Pain
  • Restless leg syndrome (a powerful urge to move your legs)
  • Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  • Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires)
  • Burning sensation
  • Tachyphrenia (abnormally rapid mental activity)
1 - 6 months:
  • Gallbladder operation
  • Muscle spasms (muscle contraction)
  • Abdominal pain upper
  • Hypoaesthesia (reduced sense of touch or sensation)
  • Motor dysfunction (dysfunction of a muscle, nerve, or centre that effects or produces motion)
  • Pelvic mass
  • Spinal column stenosis (narrowing of spinal column)
  • Head injury
  • Burning mouth syndrome (pain in the mouth and burning sensation on tongue)
6 - 12 months:
  • Muscle spasms (muscle contraction)
  • Gallbladder operation
  • Hip joint replacement
  • Abdominal pain upper
1 - 2 years:
2 - 5 years:
5 - 10 years:
  • Weight decreased
  • Dizziness
  • Mania (a state of abnormally elevated or irritable mood)
  • Balance disorder
  • Fall
  • Diarrhea
  • Fatigue (feeling of tiredness)
  • Visual impairment
  • Extranodal marginal zone b-cell lymphoma (malt type) (cancer originating from b cells in the marginal zone of the malt)
  • Hypomania (a mild form of mania, marked by elation and hyperactivity)
10+ years:
not specified:
  • Urinary tract infection
  • Insomnia (sleeplessness)
  • Constipation
  • Weight decreased
  • Diarrhea
  • Pain
  • Abdominal pain
  • Back pain
  • Tremor (trembling or shaking movements in one or more parts of your body)
  • High blood pressure

Top conditions involved for these people *:

  • Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 29.23%
  • Metastases To Bone (cancer spreads to bone): 11 people, 16.92%
  • Pain : 10 people, 15.38%
  • Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 9 people, 13.85%
  • Breast Cancer : 8 people, 12.31%

Top co-used drugs for these people *:

  • Ativan (24 people, 36.92%)
  • Protonix (22 people, 33.85%)
  • Lamictal (20 people, 30.77%)
  • Ambien (20 people, 30.77%)
  • Xyrem (19 people, 29.23%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Related publications that referenced our studies

Can you answer these questions?

More questions for: Zofran, Abilify, Nausea and vomiting, Depression

You may be interested in these posts

More posts for: Zofran, Abilify, Nausea and vomiting, Depression

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.